Home > Insider Trading > Filing (0001161697-23-000243)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1369568	Catalyst Pharmaceuticals Inc.	CPRX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1292636	S David Tierney	355 Alhambra Circle, Suite 801 Coral Gables FL 33134		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001 Per Share	Acquisiton	2023-04-05	30,000	$0.79	343,541	No	4	M	Direct
Common Stock, Par Value $0.001 Per Share	Disposition	2023-04-05	30,000	$16.83	313,541	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Options to purchase common stock	Disposition	2023-04-05	30,000	$0.00	30,000	$0.79

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
280,500		2023-06-15	No	4	M	Direct

Footnotes

Dr. Tierney has advised the Company that the sale of shares was to pay the exercise price of the shares and to raise funds for personal reasons, and does not relate to any disagreements between Dr. Tierney and the Company on any matter relating to the Company's operations, policies or practices. Dr. Tierney remains a Director of the Company.
Shares were sold in various lots from $16.70 to $16.98 per share. The listed sales price represents a weighted average price for the shares sold.
The option was granted on June 15, 2016 and previously vested in two annual installments.